VivoSeq
Other

Multimodal Analgesia

0

Pipeline Programs

9

Active Trials

0

Companies Involved

Multimodal Analgesia is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

7/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

29

clinical trials

Completed16 · 55%
Not yet recruiting4 · 14%
Recruiting3 · 10%
Unknown status2 · 7%
Active, not recruiting2 · 7%
Terminated1 · 3%
Other1 · 3%

Trial Activity

29 trials

Multimodal Analgesia vs. Femoral Block in ACL Surgery
Recruiting··N/A·NCT06936995·62 enrolled
Multimodal Analgesia Effect on Post Surgical Patient
Active, not recruiting·UUniversity of California, Davis·Phase 4·NCT04240626·60 enrolled
Assessment of PENG Block as a Part of Multimodal Analgesia Following Hip Surgeries.
Active, not recruiting··N/A·NCT06916000·50 enrolled
Perioperative Multimodal Analgesia for Supratentorial Craniotomy
Not yet recruiting··N/A·NCT07441421·2,000 enrolled
Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy
Not yet recruiting··N/A·NCT06406829·2,000 enrolled
Multimodal Analgesia Strategies After Major Shoulder Ambulatory Surgery
Completed··Phase 4·NCT04110665·92 enrolled
Multimodal Analgesia for Cholecystectomy
Completed·GGangnam Severance Hospital·Phase 3·NCT04788654·60 enrolled
ACL Repair and Multimodal Analgesia
Completed·UUniversity of Wisconsin, Madison·Phase 4·NCT01868425·112 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)